Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001672659-26-000018

Chief Medical Officer sold 417 shares at $25.65 ($10,696)

  • Chief Medical Officer acquired 417 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rodman David Malcom Chief Medical Officer 2026-03-17 Option exercise 10b5-1 +417 $15.44 $6,438 76,557 D
Rodman David Malcom Chief Medical Officer 2026-03-17 Sale 10b5-1 −417 $25.65 $10,696 76,140 D
Derivatives
Rodman David Malcom Chief Medical Officer 2026-03-17 Option exercise · Stock Option 10b5-1 −417 5,000 D
Open-market sales · 417 sh · avg $25.65 · $10,696
Loading xslF345X05/wk-form4_1773780674.xml…